🇺🇸 FDA
Patent

US 10947295

Heterodimers of soluble interferon receptors and uses thereof

granted A61KA61K38/00

Quick answer

US patent 10947295 (Heterodimers of soluble interferon receptors and uses thereof) held by Sanabio, LLC expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sanabio, LLC
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K38/00